ArticleFrontiers in oncology2014

"Omics" and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas.

Elda Tagliabue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.